Academic Hospital is a tertiary institution in Soweto, Johannesburg, affiliated with the University of the Witwatersrand. The paediatric renal department sees ~1 500 patients per year, and admits ~30 patients per month.
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Posterior reversible encephalopathy syndrome (PRES) is a neuro logical condition first described in 1996 [1] and defined as reversible subcortical vasogenic brain oedema presenting with neurological symptoms [2] including encephalopathy, seizures, headaches and visual disturbances. The diagnosis is confirmed radiologically by decreased diffusivity of cortical and subcortical brain tissue of T2weighted magnetic resonance imaging (MRI). [2, 3] The two main hypotheses of the pathogenesis of PRES are related to factors influencing cerebral perfusion and endothelial dysfunction. [4] Despite a growing number of studies describing PRES, the risk factors, symptomatology and pathophysiology are not well understood. Although PRES is well documented in the adult population, little is known about the disease process in children. A limited number of PRES diagnoses associated with renal disease in paediatric patients have been described in the literature to date, and all of these are case reports. [517] The diagnosis of PRES is important because the prognosis is generally favourable [18] and these children should be offered intensive care even in lowresource settings, where misdiagnosis may mean that they would be considered poor candidates. The diagnosis is usually made on MRI when predisposing factors and symptoms are suggestive, but it may be more sensitively detected by an electroencephalogram showing focal nonconvulsive seizures or status epilepticus. [18] We postulate that as a disease entity PRES is not entirely separate from hypertensive encephalopathy and may represent a radiographically imaged and more severe presentation of the same disease process, now identifiable because of the availability of MRI. We therefore reviewed the presentation, diagnosis and outcome of PRES in paediatric renal patients at Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa, and compared these with published case reports.
Methods
We retrospectively report on the records of five children with renal disease diagnosed with PRES at Chris Hani Baragwanath Academic Hospital between 1 January 2000 and 31 January 2017. Data pertaining to their demographics, underlying diagnosis, medical therapy, biochemi cal and haematological parameters, blood pressure, clinical presentation, radiological findings and outcome are detailed. This information is compared with all published articles on PRES in paediatric renal patients in the PubMed database. The search terms 'posterior reversible (leuko)encephalopathy syndrome' AND 'paediatric' , 'pediatric' OR 'child' AND 'renal' OR 'kidney' were used. 
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generalised tonicclonic seizures, rightsided hemiplegia and cortical blindness. These symptoms deteriorated over 2 days, and she became nonresponsive and required ventilatory support. Prior to onset of the above symptoms there had been worsening control of her blood pressure, which was 160/110 mmHg at its highest (50th centile 101/60 mmHg), [19] and worsening biochemical markers of renal function while on PD (blood urea level 10.6 mmol/L, serum creatinine 844 µmol/L, serum sodium 149 mmol/L). She had completed a course of empirical antibiotics for suspected bacterial peritonitis. Her chronic medications were prednisone (2 mg/kg), spironolactone, enalapril, folate, mycophenolate mofetil (MMF), oral potassium and phosphate replacement. She had received no recent blood transfusions, and her serum haemoglobin concentration was 8.1 g/dL. A noncontrast computed tomography (CT) image of her brain showed an area of hypodensity in the right cortex. Cranial magnetic resonance imaging (cMRI) revealed multiple areas of T2/ flair hyperintensity involving white matter in the posterior parietal lobes, occipital lobes and cerebellar white matter (Fig. 1) . A diagnosis of PRES was made, and she was ventilated, her blood pressure was treated, and her medication and PD continued. She became more responsive, and 10 days after the onset of the initial symptoms had made an almost complete neurological recovery. She was discharged with some residual righthand weakness, and dysarthria on maintenance sodium valproate. She died within 6 months of discharge from complications of her renal failure.
Case 2
A 9yearold boy known to have steroiddependent minimalchange nephrotic syndrome and hypertension was admitted with intractable seizures requiring ventilation. On admission he had elevated blood pressure (150/100 mmHg, 50th centile 100/60 mmHg) [19] and normal renal function. His blood urea level was 1.5 mmol/L, serum creatinine 40 µmol/L and serum sodium 141 mmol/L, while his haemoglobin concentration was normal at 13.3 g/dL. His chronic medications were prednisone (2 mg/kg), enalapril, spironolactone, perindopril, simvastatin and MMF. A noncontrast CT image of his brain revealed cerebral oedema, and cMRI revealed T2 hyperintensity in the frontal and parietal lobes as well as watershed infarcts. He improved rapidly with management of his blood pressure. On followup he had no residual neurological symptoms and no further seizures on maintenance sodium valproate.
Case 3
An 8yearold girl on PD for CKD due to immune complexmediated focal segmental glomerular sclerosis developed seizures and cortical blindness while in the ward. Her blood pressure was elevated (125/95 mmHg, 50th centile 96/57 mmHg) [19] and she had worsening renal function with a blood urea level of 5 mmol/L, serum creatinine 544 µmol/L and serum sodium 133 mmol/L. Her haemoglobin concentration was 10.1 g/dL, and she had not received any blood transfusion. She was managed on weaning doses of prednisone (1 mg/kg), MMF, 1alpha vitamin D, calcium, folate, potassium, thiamine and ferrous oral supplementation, erythropoietin and omeprazole. cMRI revealed extensive whitematter disease with T2/ flair hyperintensities globally. Her symptoms resolved completely within a month of onset.
Case 4
A 10yearold girl had newly diagnosed nephrotic syndrome with immune complexmediated focal segmental glomerular sclerosis. Having been pulsed with methylprednisone and on prednisone (2 mg/kg), she developed transient visual loss and seizures and was brought to hospital. Her blood pressure was also elevated (144/99 mmHg, 50th centile 99/59 mmHg) [19] and she had an elevated blood urea level of 8.6 mmol/L, serum creatinine 103 µmol/L and serum sodium 141 mmol/L. Her haemoglobin concentration was 10.6 g/ dL. Her medication included prednisone (2 mg/kg), antituberculosis treatment, spironolactone, amlodipine, doxazosin and simvastatin. cMRI was unavailable at the time, and CT imaging showed some hypodensities in the parietal and occipital lobes. Her visual loss resolved with blood pressure control, and she is now well.
Case 5
A 10yearold girl on PD with endstage renal disease secondary to HIVassociated nephropathy was admitted with a history of new onset focal seizures. On admission her blood pressure was elevated (168/130 mmHg, 50th centile 100/59 mmHg).
[19] Her blood urea level was 11.2 mmol/L, serum creatinine 779 µmol/L and serum sodium 135 mmol/L. Her haemoglobin concentration was 10.1 g/dL, She was on antiretroviral treatment, enalapril, amlodipine, metoprolol, folate, calcium carbonate, vitamin D, erythropoietin and prednisone (2 mg/ kg). CT imaging identified multifocal whitematter hypodensitites and a thinned cortex. cMRI T2/flair identified hyperintensities in the parietal and occipital lobes. She was started on sodium valproate, with good seizure control and no neurological deficit.
Review of the literature
We identified 12 published case reports or series describing 64 children aged between birth and 14 years of age with renal disease who had been diagnosed with PRES.
[517] Their mean age was 9.1 years. There were 24 males, 24 females and 16 of unreported sex. The baseline diagnoses of all the reviewed patients (N=64) are shown in Fig. 2 . Most reviewed patients (91%), and all the newly reported patients, had hypertension at the time of onset of symptoms. Thirty five of the 64 reviewed patients were on immunosuppressive drugs, 3 were receiving haemodialysis and 5 PD, and 4 had undergone renal transplants.
Seizures were the presenting symptom in 91% of cases, an altered level of consciousness in 63%, headaches in 50% and visual disturbances in 41% (Fig. 3) . The radiological cMRI diagnosis mostly involved changes
Fig. 1. Case 1. T2/flair magnetic resonance image showing multiple hyper intensities (arrows).
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in the occipital lobe (91%), but also in the parietal lobe (73%), frontal lobe (36%) and temporal lobe (39%) (Fig. 4) . Complete recovery was reported in 87.5% of cases, residual epilepsy in 5% and recurrence of PRES in 5%; there was one report of other nonspecified neurological sequelae, and one patient was lost to followup.
Discussion
The five newly reported cases are similar to those reviewed in the literature in terms of age at presentation (mean 9.6 years, literature review 9.5 years). There were equal numbers of female and male patients in the 64 reviewed children, but four of the five newly repor ted cases were female. Because of the limited cohort size it is difficult to comment on the significance of this finding, but it is in keeping with existing literature reporting that more females than males develop PRES. [5] Four of the five reported cases had nephrotic syndromerelated diagnoses, while 48% of the reviewed cases were similarly afflicted (although this figure may be higher, as 19% of the reviewed cases were reported to be in endstage renal disease without a specified underlying diagnosis). Three of the five reported cases were in end stage renal disease and undergoing renal replacement therapy, and only one patient had a normal estimated glomerular filtration rate. This represents a higher proportion of patients with advanced renal disease than that reflected in the literature. The development of PRES as a complication of PD or uraemic encephalopathy therefore does not fully explain the pathogenesis in all the cases.
Only one of the five reported cases and 11% of the reviewed cases had been diagnosed with systemic vasculitis at the time of PRES diagnosis. In keeping with the hypothesis that the pathogenesis of PRES is related to endothelial inflammation, [4] this would suggest that a process other than vasculitis caused the implicated inflammation in these cases. Importantly, all the reported patients and 91% of the reviewed patients were hypertensive at the time of PRES diagnosis. Only one patient diagnosed with renovascular hypertension was diagnosed with PRES in the reviewed literature. All the reported patients were hypertensive on medication prior to symptom development. However, it is surprising that no patient with Takayasu's arteritis or other renovascular hypertensive disease seen in our department has developed PRES. We postulate that PRES may be related to the rate of rise of blood pressure instead of the sustained levels of hypertension in these patients.
Although PRES associated with blood transfusion has been reported in the literature, [20] this was not observed in our patients. One of the five reported patients had a haemoglobin concentration <10 g/dL, and none had received blood transfusion prior to the development of symptoms. This was not universally reported on in the reviewed patients. All the reported patients were on prednisone at the time of onset of symptoms, and two were on other immunosuppressive therapy (MMF). All the reported patients had normal serum sodium levels.
The most common presenting symptom in the literature was seizures (91%), and all the reported patients presented with seizures. There are reports that PRES may be considered an epileptic disorder, [18] and that it could be monitored or predicted by electroencephalography, which would show either focal nonconvulsive seizures or status epilepticus. However, three of the five reported patients were not treated with maintenance antiepileptic drugs and have not had recurrences of seizures. The need for maintenance antiepileptic medication should be reviewed, especially in this patient group, as they require multiple drugs for renal failure and the underlying disease.
The pattern of cMRI changes at PRES diagnosis reviewed in the literature showed a predominance of occipital and parietal changes, which is consistent with the reported cases in which this imaging modality was available. It also to some extent explains the frequency of visual disturbances present at the time of diagnoses (three of six of the reported cases, and 41% of the reviewed cases). Most (87.5%) of the reviewed cases had radiological recovery as seen on followup MRI. Repeat imaging was not requested in the reported patients
The followup of our five patients ranged from a few months to many years, with a mean of 28 months. All five of these patients recovered from their presentation with PRES, four without any neurological deficit. There were no reported recurrent episodes. The literature review revealed complete recovery in 87.5% of patients. This good recovery suggests that PRES is a transient syndrome with a favourable outcome if identified correctly and managed appropriately.
Study limitations
This was a retrospective analysis of medical records spanning a 17year period. Selection bias is likely to have been introduced because only patients referred to the renal service were included. 
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Recommendations
Based on our experience and a review of the literature:
• The good prognosis associated with PRES should be considered when a decision about intensive care in lowresource settings is made.
• Repeat MRI is probably not indicated in patients who have undergone a full neurological recovery.
• The need for maintenance antiepileptic medication should be determined.
• The usefulness and availability of electroencephalography should be determined in this population.
Conclusions
All the reported cases of PRES presented clinically as hypertensive emergencies and radiologically with PRES, and most had a complete neurological recovery. These case reports support the hypothesis that PRES represents the radiological manifestation of a hypertensive emergency, now identified since the advent of MRI technology. However, the question why this syndrome does not seem to occur in patients with Takayasu's arteritis and other renovascular hypertensive disease, where hypertension is frequently severe, highlights the probability that there are as yet unidentified processes that result in the condition. The need for maintenance antiepileptic treatment remains to be determined.
